Browse by Uncontrolled Keywords
Number of items: 6.
Bibliographic data only
Croft, SL;
Seifert, K;
Duchene, M;
(2003)
Antiprotozoal activities of phospholipid analogues.
Molecular and biochemical parasitology, 126 (2).
pp. 165-72.
ISSN 0166-6851
DOI: https://doi.org/10.1016/S0166-6851(02)00283-9
Full text not available from this repository.
Escobar, P;
Matu, S;
Marques, C;
Croft, SL;
(2002)
Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.
Acta tropica, 81 (2).
pp. 151-7.
ISSN 0001-706X
DOI: https://doi.org/10.1016/S0001-706X(01)00197-8
Full text not available from this repository.
Escobar, P;
Yardley, V;
Croft, SL;
(2001)
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Antimicrobial agents and chemotherapy, 45 (6).
pp. 1872-5.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.45.6.1872-1875.2001
Full text not available from this repository.
Guerin, PJ;
Olliaro, P;
Sundar, S;
Boelaert, M;
Croft, SL;
Desjeux, P;
Wasunna, MK;
Bryceson, ADM;
(2002)
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
The Lancet infectious diseases, 2 (8).
pp. 494-501.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(02)00347-X
Full text not available from this repository.
Olliaro, PL;
Ridley, RG;
Engel, J;
Sindermann, H;
Bryceson, ADM;
(2003)
Miltefosine in visceral leishmaniasis.
The Lancet infectious diseases, 3 (2).
p. 70.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(03)00512-7
Full text not available from this repository.
Public
Sundar, S;
Jha, TK;
Thakur, CP;
Engel, J;
Sindermann, H;
Fischer, C;
Junge, K;
Bryceson, A;
Berman, J;
(2002)
Oral miltefosine for Indian visceral leishmaniasis.
The New England journal of medicine, 347 (22).
pp. 1739-46.
ISSN 0028-4793
DOI: https://doi.org/10.1056/NEJMoa021556